According to our previous report on the same cohort, cftDNA carrying KRAS point mutations in the G12, G13, and Q61 hotspots was significantly associated with such parameters as serum CA19-9 levels, presence of distant metastases, and the size of the tumor [21]. Here, KRAS is linked to neoplasm.